These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
540 related items for PubMed ID: 19442795
1. [One year follow-up of patients with bullous pemphigoid]. Doffoel-Hantz V, Sparsa A, Marin B, Durox H, Bonnetblanc JM, Bédane C. Ann Dermatol Venereol; 2009 May; 136(5):407-11. PubMed ID: 19442795 [Abstract] [Full Text] [Related]
2. [Cutaneous infections in bullous pemphigoid patients treated with topical corticosteroids]. Boughrara Z, Ingen-Housz-Oro S, Legrand P, Duong TA, Roujeau JC. Ann Dermatol Venereol; 2010 May; 137(5):345-51. PubMed ID: 20470914 [Abstract] [Full Text] [Related]
3. [Efficacy of rituximab in a case of refractory bullous pemphigoid]. Reguiaï Z, Tchen T, Perceau G, Bernard P. Ann Dermatol Venereol; 2009 May; 136(5):431-4. PubMed ID: 19442800 [Abstract] [Full Text] [Related]
10. Juvenile bullous pemphigoid: the presentation and follow-up of six cases. Gajic-Veljic M, Nikolic M, Medenica L. J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):69-72. PubMed ID: 19453790 [Abstract] [Full Text] [Related]
11. Clinicoepidemiological features and course of 43 cases of bullous pemphigoid in Kuwait. Nanda A, Al-Saeid K, Al-Sabah H, Dvorak R, Alsaleh QA. Clin Exp Dermatol; 2006 May; 31(3):339-42. PubMed ID: 16681571 [Abstract] [Full Text] [Related]
12. Survival after recurrence of osteosarcoma: a 20-year experience at a single institution. Crompton BD, Goldsby RE, Weinberg VK, Feren R, O'Donnell RJ, Ablin AR. Pediatr Blood Cancer; 2006 Sep; 47(3):255-9. PubMed ID: 16123980 [Abstract] [Full Text] [Related]
13. Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy. Thorne JE, Woreta FA, Jabs DA, Anhalt GJ. Ophthalmology; 2008 Dec; 115(12):2146-2152.e1. PubMed ID: 18930554 [Abstract] [Full Text] [Related]
14. Bullous pemphigoid: course of the disease. A study of 25 patients. Carro-Jiménez EJ, Sánchez JL. Bol Asoc Med P R; 2003 Dec; 95(4):27-8, 33-5. PubMed ID: 15032026 [Abstract] [Full Text] [Related]
17. [Prospective study of treatment of bullous pemphigoid by a class I topical corticosteroid]. Zimmermann R, Faure M, Claudy A. Ann Dermatol Venereol; 1999 Jan; 126(1):13-6. PubMed ID: 10095883 [Abstract] [Full Text] [Related]
18. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid. Beissert S, Werfel T, Frieling U, Böhm M, Sticherling M, Stadler R, Zillikens D, Rzany B, Hunzelmann N, Meurer M, Gollnick H, Ruzicka T, Pillekamp H, Junghans V, Bonsmann G, Luger TA. Arch Dermatol; 2007 Dec; 143(12):1536-42. PubMed ID: 18087004 [Abstract] [Full Text] [Related]
19. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. Joly P, Roujeau JC, Benichou J, Picard C, Dreno B, Delaporte E, Vaillant L, D'Incan M, Plantin P, Bedane C, Young P, Bernard P, Bullous Diseases French Study Group. N Engl J Med; 2002 Jan 31; 346(5):321-7. PubMed ID: 11821508 [Abstract] [Full Text] [Related]
20. Liver transplantation for primary biliary cirrhosis: results of aggressive corticosteroid withdrawal. Campsen J, Zimmerman M, Trotter J, Wachs M, Bak T, Steinberg T, Kaplan M, Kam I. Transplant Proc; 2009 Jun 31; 41(5):1707-12. PubMed ID: 19545712 [Abstract] [Full Text] [Related] Page: [Next] [New Search]